MYCN and neuroblastoma: Importantly, BET bromodomain-mediated inhibition of MYCN suppresses neuroblastoma growth both in vitro and in vivo (97). Similarly, OTX015 (Oncoethix), a small molecule that prevents BRD2/3/4 from binding to acetylated histones, also represses MYCN transcription.